How long do neutrophils circulate

An ongoing infection will promote neutrophilia, which may lead to excessive inflammation and tissue damage, thus neutrophil recruitment and action has to be tightly regulated. Recent reports describe a neutrophil subset producing the immunosuppressive cytokines IL in response to bacterial and fungal infections.

In acute mycobacterial infection, the inflammatory response of monocytes and macrophages is damped by the secretion of large amounts of IL from neutrophils Zhang et al.

While it has been demonstrated that a cell—cell contact with LPS-activated regulatory T cells triggers the IL production by neutrophils Lewkowicz et al.

However, in a model of simulated sepsis in humans LPS injection in healthy volunteers , an anti-inflammatory subset of neutrophils that surfaced during late stages of simulated sepsis was detected Pillay et al.

In this, and in a follow-up study, the authors found a subset of mature neutrophils with hypersegmented nuclei defined as CD16 bright CD62L dim which suppressed T cell activation through release of ROS Pillay et al. Thus, heterogeneity within the neutrophil population during infection has been demonstrated in multiple scenarios, and different subsets have clearly defined roles in promoting and suppressing the inflammatory response.

Following the inflammatory phase, neutrophils also participate in tissue remodeling during the restitution phase. The N1 cells were, on the other hand, involved in ventricular wall thinning when lingering in the tissue, because of their release of proteases.

This was the first time a stark division of neutrophil polarization was found in an ischemic model. Our group recently described a distinct neutrophil subtype that was recruited by vascular endothelial growth factor VEGF -A to sites of tissue hypoxia, where they display a pro-angiogenic phenotype Massena et al. We have also found that the pro-angiogenic neutrophils display higher levels of the chemokine receptor CXCR4 and content of the matrix metalloproteinase MMP -9 compared to neutrophils recruited to inflammatory sites.

After being recruited to hypoxic areas, they interact with sprouting endothelium Christoffersson et al. The involvement of neutrophils in both prevention and promotion of tumor progression has been suggested for several decades, and contradictory evidence has fuelled the controversy about the role of neutrophils in cancers. A confounding cell type when studying neutrophils in tumors is the myeloid-derived suppressor cell MDSC , which shares morphological features with neutrophils and the expression of the surface marker Gr These MDSC exerts a ROS- and arginase1-dependent immunosuppressive function on T cell proliferation and activation, and thereby limit the endogenous anti-tumor response Marvel and Gabrilovich Thus, most defining features of MDSCs are functional features and intracellular proteins making the immediate distinction from neutrophils difficult.

In their seminal study, Fridlender and colleagues showed that neutrophils in tumors could be divided into two separate subsets based on their pro- and anti-tumor functions, as well as their expression and morphology Fridlender et al. Anti-tumoral tumor-associated neutrophils TANs N1 are characterized by high production of pro-inflammatory cytokines, an hypersegmented nuclei, and high tumor-cell-killing abilities, whereas the N2 subtype is characterized by an increased arginase content, an immature morphology, and displays tumor-promoting function Fridlender et al.

The transcriptomic analysis of these subsets compared to MDSC and naive neutrophils isolated from tumor-free mice showed that they were indeed three distinct subsets Fridlender et al. The authors also suggested that immature LDG neutrophils are released from the bone marrow before the termination of the maturation steps. On the other hand, the possibility that LDG neutrophils acquired their density phenotype and suppressive functions in parallel processes is supported by LDGs isolated from systemic lupus erythematosus patients which do not display immunosuppressive features Denny et al.

Intriguingly, results from in vitro experiments showed that degranulation of circulating neutrophils could be a prerequisite to their acquisition of the low-density and immunosuppressive features Rodriguez et al.

The ability of solid tumors to affect hematopoiesis and thereby the fate and phenotype of circulating neutrophils was recently demonstrated Engblom et al. This study shows that lung adenocarcinomas activate osteoblasts at distant sites, which drive tumor progression by supplying them with pro-tumorogenic neutrophils expressing high levels of Siglec-F sialic acid-binding immunoglobulin-like lectin F.

These specific neutrophils attained most of their protumor-effects at the tumor site, but higher levels of Siglec-F was found on circulating neutrophils in tumor-bearing mice, and correlated with worse outcome in patients with lung adenocarcinomas.

The mechanisms by which the tumor directly affect hematopoiesis remain to be full uncovered, but seems to involve increased levels of circulating RAGE receptor for advanced glycation end products. It is evident that neutrophil functions go well beyond those of the kamikaze cells predestined to find and kill bacteria before dying at the site of infection.

Many studies have demonstrated that apart from their important role in host defense, neutrophils are also crucial actors in angiogenesis, tissue restoration and resolution of inflammation. In addition, new studies reveal specific functions of the marginated pools that reside in distinct organs with large vascular beds, and thereby enabling vast neutrophil—endothelial cell interactions or even microenvironmental instructions.

However, further investigations, such as sequencing of the transcriptomes of the defined neutrophil subpopulations, will uncover their individual toolboxes and potential fate.

In addition, lineage-tracing experiments are needed to unequivocally answer the question whether these various functions are performed by neutrophil populations of distinct origin or by neutrophils at different levels of maturations or with different education.

Int J Cancer — The total blood, circulating and marginal granulocyte pools and the granulocyte turnover rate in normal subjects. J Clin Invest — Blood — Article PubMed Google Scholar.

Campbell FR Ultrastructural studies of transmural migration of blood cells in the bone marrow of rats, mice and guinea pigs. Am J Anat — Nat Med — Lab Investig — J Leukoc Biol — Cline MJ Phagocytosis and synthesis of ribonucleic acid in human granulocytes. Nature — J Exp Med — J Immunol — J Appl Physiol — PubMed Google Scholar. Clin Exp Immunol — Cancer Cell — J Acquir Immune Defic Syndr — Biosci Rep — J Biol Chem — North-Holland, Amsterdam.

Google Scholar. Mucosal Immunol — PLoS Genet e Immunity — J Biomed Sci Cardiovasc Res — Marvel D, Gabrilovich DI Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected. A method for Labeling granulocytes in vitro with radioactive Diisopropylfluorophosphate Dfp.

J Innate Immun — Nat Immunol — Cancer Res — Cell Rep — Sinha S, Zhu QS, Romero G, Corey SJ Deletional mutation of the external domain of the human granulocyte colony-stimulating factor receptor in a patient with severe chronic neutropenia refractory to granulocyte colony-stimulating factor. J Pediatr Hematol Oncol — Trends Immunol — Clin Immunol — Theilgaard-Monch K, Knudsen S, Follin P, Borregaard N The transcriptional activation program of human neutrophils in skin lesions supports their important role in wound healing.

PLoS Pathog 8:e Science — Infect Immun — Sci Immunol. Download references. Cedric Seignez is acknowledged for constructive input on the content of this review. Box , 23, Uppsala, Sweden. You can also search for this author in PubMed Google Scholar. Correspondence to Mia Phillipson. Reprints and Permissions. Christoffersson, G. The neutrophil: one cell on many missions or many cells with different agendas?.

Cell Tissue Res , — Download citation. Received : 23 October Accepted : 19 December Published : 12 February When attracted by chemokines, they extravasate into tumor tissue where they are activated to delay apoptosis and engage in the inflammatory tumor microenvironment. A fraction of activated neutrophils may reverse migrate and home back to the bone marrow which shapes further neutrophil release. The tumor-invading neutrophils are exposed to hypoxia as well as cancer and stroma cell signals, which can trigger the formation of neutrophil extracellular traps NETs.

NET components such as oxidized DNA may stimulate an inflammatory response by macrophages or dendritic cells. NET-associated proteases alter the extracellular matrix and NET-derived HMGB1 molecules activate cancer cells to jointly promote tumor cell proliferation, migration, invasion, and metastasis.

There is a considerable variety of different ways for neutrophils to die which entail distinct consequences in health and disease. To date apoptosis, pyroptosis, necrosis, necroptosis, autophagic cell death, and NETosis have been described The survival time of mature neutrophils is subject to regulation by both, the intrinsic and the extrinsic pathway of apoptosis. However, their balance of pro- and anti-apoptotic members of the Bcl-2 superfamily differs from other cell types Mature neutrophils exhibit low expression of Bcl-2 but high levels of Mcl-1 The data on the expression of Bcl-xL protein are controversial.

If apoptotic neutrophils are not removed in time, they progress toward secondary necrosis. This is associated with a passive release of caspase 3-processed IL-6C tetramers and MIF oligomers, which are considered to act as danger signals Of interest, some pathogens interfere with phagocytosis-induced cell death and extend the lifespan of neutrophils to promote their own replication within the cells A mechanism to prevent such a replication is pyroptosis.

Neutrophil death by necrosis is usually a trigger for inflammation It may occur in a regulated fashion. Another option of neutrophil cell death was discovered in when NETs were first described as expelled DNA strands decorated with neutrophil proteins and intended to entrap and eliminate pathogens It was found that the decondensed DNA is suited to entangle microorganisms and that associated histones are highly toxic.

Furthermore, neutrophilic enzymes such as MPO or elastase contribute to pathogen destruction 24 , Although the formation of NETs was originally described as a particular type of neutrophil cell death and hence termed NETosis, it was subsequently found that NETs may also be generated without immediate cell death The nuclear translocation of these enzymes allows for histone cleavage, chromatin decondensation, and further pore formation in granule as well as cytosolic membranes Although this pathway is triggered by, e.

Chromatin decondensation may be facilitated by the enzyme peptidylarginine deiminase 4 PAD4 , which mediates histone citrullination 30 and has been shown to contribute to the antibacterial defense against Shigella flexneri and group A Streptococcus pyogenes As the mitochondrial DNA is less protected by complexed proteins, it is highly oxidized during the process and constitutes a major pro-inflammatory trigger when released during NET formation 31 , 32 , Apoptotic cells can be removed by various categories of phagocytes via efferocytosis.

It represents a version of stimulated micropinocytosis and is distinct from the classical phagocytosis of microbes 7. The most prominent eat-me signal on the surface of apoptotic cells is phosphatidylserine, which is recognized by different receptors in the phagocytic synapse. The involved signal pathways have been described extensively elsewhere 34 , Apoptotic neutrophils upregulate annexin-I and calreticulin on their surface which act as supplementary eat-me signals Blockade of a single receptor has never been shown to completely abolish efferocytosis, suggesting that either redundant efferocytosis pathways exist or individual receptors cooperate with other receptors.

Efferocytosis activates an inflammosuppressive and immunosuppressive response in the phagocyte Upon engulfment of dying cells, LC3 is recruited to the dead cell-containing phagosome The anti-inflammatory response relies on a prolonged presence of apoptotic cells A short exposure has no effect. Interestingly, efferocytosis of neutrophils with surface exposed granule protein PR3 promotes a pro-inflammatory rather than anti-inflammatory response Efferocytosis has been shown not only to contribute to the resolution of inflammation but also to promote the proliferative and remodeling phases of tissue repair reviewed in ref.

It activates the synthesis of lipoxins, DHA products, and E series resolvins and decreases their production of classical eicosanoids 39 , These pro-resolving lipid mediators collectively reduce vascular permeability, inhibit further neutrophil transmigration, promote recruitment of non-phlogistic monocytes, induce neutrophil apoptosis and promote their efferocytosis, creating a positive feedback in favor of resolution.

It is well accepted that also neutrophils themselves have the capacity to efferocytose apoptotic cells but there is very little literature available. In response to tissue injury, local neutrophils initiate a highly coordinated form of chemotaxis of further neutrophils involving a sequence of auto- and paracrine signaling of chemokines, lipids, and chemoattractants This suggests that efferocytosis of apoptotic cell debris by neutrophils is a frequent event in an inflamed tissue or in a tumor microenvironment and may contribute to a considerable degree to the local resolution of inflammation und tissue regeneration.

Deregulated neutrophil apoptosis is often linked to disease. An increased rate has been reported in different neurodegenerative disorders In contrast, autoimmune diseases and cancer are frequently associated with reduced neutrophil apoptosis Many solid tumors including colorectal cancer, lung cancer and breast cancer are characterized by a high neutrophil infiltration 46 , 47 , However, its predictive value differs between cancer types 8. Tumor-associated neutrophils show a prolonged lifespan Fig.

Numerous different survival factors for neutrophils have been described, including cytokines, chemokines, hormones, lipid mediators, and DAMPs summarized in ref. Furthermore, DAMPs released from dying cells in response to tumor-associated tissue damage are able to prolong neutrophil lifespan 3.

Finally, also physicochemical conditions in the tumor microenvironment can promote neutrophil survival. For example, hypoxia activates an oxygen-sensing prolyl hydroxylase 3 in neutrophils, which mediates an increase of anti-apoptotic Bcl-x L Tissue-infiltrating neutrophils that are attracted by tumor-derived signals are exposed to a variety of survival factors originating from tumor cells, stroma, hypoxia, or dying cells.

They may propagate the inflammatory tumor microenvironment by recruiting and activating further leukocytes, such as cytotoxic T-cells. Tumor-associated neutrophils have the potential to reverse migrate into circulation, thereby facilitating metastasis of attached tumor cells. However, the majority of them is proposed to undergo local apoptosis and subsequent efferocytosis by macrophages, which drives an anti-inflammatory M2-like polarization, tumor proliferation, and vascularization.

Conversely, neutrophils may remove apoptotic tumor cells by efferocytosis and thereby promote tissue remodeling and cancer growth. Although the final fate of tumor-associated neutrophils when they reach the end of their life time is not well characterized it is generally assumed that the majority of tumor-associated neutrophils undergo local apoptosis.

It has been proposed that efferocytosis in the tumor microenvironment mediates an M2-like polarization of tumor-associated macrophages and that the related anti-inflammatory and pro-resolving response contributes to tumor growth and vascularization 52 Fig. Furthermore, recent studies in breast cancer and melanoma models revealed that a part of tumor-associated neutrophils migrate reversely into the blood flow and are finally cleared in the bone marrow.

Some of them aggregate with cancer cells before leaving the tumor microenvironment and promote their spreading 53 , Apart from the beneficial impact of NETs in combating infections, their detrimental role in the pathophysiology of many non-infectious diseases has been the focus of research in recent years The very same components that confer pathogen defense are also found toxic to the host environment.

Although neutrophil-derived peroxidases and proteases contribute to extracellular matrix destruction, histones seem to be another prime culprit of damage Externalized histone H4 was found to propagate cell death and inflammation by inducing lysis of tissue cells. Thus, NETs have been detected in numerous chronic inflammatory diseases and reported to substantially contribute to pathogenesis. In respiratory disorders such as cystic fibrosis and chronic obstructive pulmonary disease, NETs were found to block airways, contribute to fibrotic regions that foster bacterial replication and convey stimulatory signals to surrounding macrophages 57 , With respect to vascular disorders, a promoting function of NETs in atherosclerosis has been reported based on the analysis of ApoE-deficient mice lacking the neutrophil proteases elastase and PR3 The loss of NETs in cholesterol-rich areas was associated with a threefold decrease in atherosclerotic lesions.

With respect to the mechanism, cholesterol crystals were shown to trigger NETosis, which then promoted the activation of macrophages. NETs are thus participating in the inflammatory process of atherosclerosis, which may ultimately lead to arterial thrombotic events.

However, NETs are also directly involved in thrombosis. The interaction of activated platelets with neutrophils at the site of plaque rupture is believed to trigger NETosis and the accumulation of active tissue factor on NETs 60 , Furthermore, NETs seem to provide a scaffold for platelet, erythrocyte, and fibrin deposition, and NET-exposed histones as well as neutrophil proteases such as elastase and cathepsin G are known to further promote platelet activation and to degrade inhibitors of coagulation In particular, extracellular histones were found to activate platelets via TLR2 and TLR4, thereby inducing a procoagulant platelet phenotype In addition to cholesterol, crystals, also urate crystals, in gout patients have been reported to trigger NET formation.

The concept of beneficial versus detrimental forms of NETs was further extended to other types of non-infectious disease 67 , Therefore, it seems of importance to carefully characterize the mechanisms of NET formation associated with distinct disorders. In line, it has recently been revealed that oxidized mitochondrial DNA rather than nuclear DNA expelled during NETosis drives damaging inflammatory reactions via dendritic cell activation and release of interferon alpha in patients with systemic lupus erythematosus SLE 69 , These patients were shown to accumulate a population of low-density granulocytes with an enhanced capacity for mitochondrial ROS production and mitochondrial NET formation.

As a trigger for NETosis, autoreactive antibodies were identified. When mitochondrial ROS production was blocked in a mouse model of SLE, disease symptoms were significantly reduced 31 , In the cancer setting, NETs were shown to promote metastasis, support the survival of tumor cells in circulation and even stimulate tumor invasion 71 , Specifically, cancer cells as well as intratumoral hypoxia were identified as inducers of NET formation, and NET-associated HMGB1 was found to activate cancer cells to promote their adhesion, proliferation, migration, and invasion 73 Fig.

NETs induced by a pro-inflammatory trigger mediated the proteolytic remodeling of the matrix component laminin to reveal a novel epitope that triggered proliferation of dormant cancer cells via integrin activation All the data listed above confirm that apart from the role of active neutrophils in health and disease their influence on immune reactions and chronic disorders extends to the stage of neutrophil death.

Although programmed cell death controls the lifespan and non-immunogenic clearance of cells, deregulated neutrophil apoptosis promotes chronic diseases like cancer by supporting stroma remodeling and metastasis.

Alternatively, neutrophils may undergo a sudden suicidal form of cell death termed NETosis where expelled DNA—protein structures are highly toxic and proteolytic. In addition to their function in pathogen defense, NETs have been found in chronic inflammatory disorders.

In particular, matrix remodeling, tumor growth, and metastasis are supported by components of this specific form of neutrophil death.

Neutrophils have become a prime target for medical intervention and an impressive number of clinical trials have been initiated in the last years Table 1. Most studies focus on chronic diseases. However, their therapeutic approaches differ strongly from each other. Some studies apply neutrophil inhibitory strategies. Others try to inhibit neutrophil cell death. It inhibits neutrophil apoptosis and stimulates neutrophil recruitment.

Similar anti-apoptotic effects have been described for corticosteroids such as fluticasone or prednisolone. Blocking the IL-6 receptor with the antibody tocilizumab reduces the number of circulating neutrophils by an increased margination into the bone marrow. Also colchicine has inhibitory effects on neutrophils. It prevents the activation of the inflammasome and reduces neutrophil adhesion and recruitment. The increasing numbers of clinical studies confirm the central role of living and dying neutrophils in the various physiological and pathological conditions.

The divergent therapeutic approaches that are applied reflect the fact that their contribution to the pathophysiology is highly disease-specific. Orr, Y. A kinetic model of bone marrow neutrophil production that characterizes late phenotypic maturation. Hidalgo, A. The neutrophil life cycle. Trends Immunol. Geering, B. Living and dying for inflammation: neutrophils, eosinophils, basophils. Mayadas, T.

The multifaceted functions of neutrophils. CAS Google Scholar. Wang, J. Visualizing the function and fate of neutrophils in sterile injury and repair. Science , — Neutrophil migration in infection and wound repair: going forward in reverse.

Janssen, W. Myeloid cell turnover and clearance. Shaul, M. Tumour-associated neutrophils in patients with cancer. Google Scholar. Soehnlein, O. Neutrophils as protagonists and targets in chronic inflammation.

Ley, K. Neutrophils: new insights and open questions. PubMed Google Scholar. Many ways—one destination: different types of neutrophils death. Peculiarities of cell death mechanisms in neutrophils.

Cell Death Differ. Moulding, D. BCL-2 family expression in human neutrophils during delayed and accelerated apoptosis. Roth, S. IL and MIF: messengers beyond neutrophil cell death. Cell Death Dis. Zhang, B. McCracken, J. Francisella tularensis modulates a distinct subset of regulatory factors and sustains mitochondrial integrity to impair human neutrophil apoptosis. Innate Immun. Liu, L.

Neutrophil pyroptosis: new perspectives on sepsis. Cell Mol. Life Sci. Ryu, J. Neutrophil pyroptosis mediates pathology of P. Mucosal Immunol. Grecian, R. The role of neutrophils in cancer.

Galluzzi, L. Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death Wang, X. Germic, N. Regulation of the innate immune system by autophagy: neutrophils, eosinophils, mast cells, NK cells. Brinkmann, V. Neutrophil extracellular traps kill bacteria. Fuchs, T. Novel cell death program leads to neutrophil extracellular traps. Cell Biol. Hirsch, J. Bricidal action of histone. Boeltz, S. To NET or not to NET:current opinions and state of the science regarding the formation of neutrophil extracellular traps.

Papayannopoulos, V. Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. Bianchi, M. Blood , —